195 related articles for article (PubMed ID: 2507222)
1. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
Hoban D; DeGagne P; Witwicki E
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of temafloxacin against pathogens causing sexually transmitted diseases.
Segreti J
Am J Med; 1991 Dec; 91(6A):24S-26S. PubMed ID: 1662891
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
[TBL] [Abstract][Full Text] [Related]
6. Comparative in-vitro activity of sparfloxacin against genital pathogens.
Perea EJ; Aznar J; Garcia-Iglesias MC; Pascual A
J Antimicrob Chemother; 1996 May; 37 Suppl A():19-25. PubMed ID: 8737122
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
Talbot H; Romanowski B
Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473
[TBL] [Abstract][Full Text] [Related]
10. The role of fluoroquinolones in sexually transmitted diseases.
Tartaglione TA; Hooton TM
Pharmacotherapy; 1993; 13(3):189-201. PubMed ID: 8321733
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effect of NY-198 (lomefloxacin) for sexually transmitted disease--bacteriological effect of U. urealyticum].
Kawamura N; Nishizawa K; Kawashima T; Koinuma A; Ohhara K
Kansenshogaku Zasshi; 1990 Jan; 64(1):1-11. PubMed ID: 2335746
[TBL] [Abstract][Full Text] [Related]
13. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
Segreti J; Kessler HA; Kapell K; Trenholme GM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
[TBL] [Abstract][Full Text] [Related]
15. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
[TBL] [Abstract][Full Text] [Related]
16. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
Kenny GE; Hooton TM; Roberts MC; Cartwright FD; Hoyt J
Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
Wright DN; Saxon B; Matsen JM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
[TBL] [Abstract][Full Text] [Related]
19. Highly specific and efficient primers for in-house multiplex PCR detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis and Ureaplasma urealyticum.
Aguilera-Arreola MG; González-Cardel AM; Tenorio AM; Curiel-Quesada E; Castro-Escarpulli G
BMC Res Notes; 2014 Jul; 7():433. PubMed ID: 24997675
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]